References
- Zvaifler N J. The immunopathology of the joint inflammation in rheumatoid arthritis. Adv Immunol 1973; 16: 265–336
- Shiozawa S, Shiozawa K. A review of the histopathological evidence on the pathogenesis of cartilage destruction in rheumatoid arthritis. Scand J Rheumatol 1988; 17(Suppl 74)65–72
- Barrett A J. The possible role of neutrophil proteinasea in damage to articular cartilage. Agents Actions 1978; 8: 11–7
- Fontana A, Hentagartner H, Fehr K, Grob G. Interlcukin-I activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1982; 2: 49–56
- Saxne T, Palladino M A, Heinegdrd D, Wollheim F A. Detection of tumor necrosis factor a, but not tumor necrosis factor α, in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988; 31: 1041–5
- Schmidt J A, Mizel S B, Cohen D, Green I, Interleukin I. A potent regulator of growth. J Immunol. 1982; 128: 2177–82
- Dayer J M, Beutler B, Cerami A. Cachectin/Tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985; 162: 2163–8
- Pettipher E J, Higgs G A, Henderson B. Interleukin-1 induces leukocyte infiltration and cartilage degradation in the synovial joint. Proc Natl Acad Sci USA. 1986; 71: 295–301
- Chu C Q, Field M, Feldmann M, Maini R N. Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1125–32
- Deleuran B W, Chu C Q, Field M, Brennan F, Mitchell T, Feldmann M, et al. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction patients in with rheumatoid arthritis. Arthritis Rheum 1992; 35: 1170–8
- Deleuran B W, Chu C Q, Field M, Brennan F, Katsikis P, Feldmann M, et al. Localization of interleukin 1, type 1 interleukin 1 receptor and interleukin 1 receptor antagonist protein in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Br J Rheumatol 1992; 31: 801–9
- Matsushima K, Morishita K, Yoshimura T, Luva T, Kobayashi Y, Lew W, et al. Molecular cloning of a human monocyte derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor and immune interferon. J Exp Med 1986; 167: 1883–93
- Koch A E, Kunkel S L, Burrows J C, Evanoff H L, Haines G K, Pope R M, et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991; 147: 2187–95
- Larsen C G, Anderson A O, Appella E, Oppenheimn J J, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243: 1464–6
- Kristensen M S, Paludan K, Larsen C G, Zachariae C OC, Deleuran B W, Jensen P KA, et al. Quantitative determination of IL-1α-induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibroblasts, endothelial cells, and monocytes. J Invest Dermatol 1991; 97: 506–10
- Van Damme J, Bunning R AD, Conings R, Russell R GG, Opdenakker G. Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin-8. Cytokine 1990; 2: 106–11
- Elford P R, Cooper P H. Induction of neutrophil-mediated cartilage degradation by interleukin-8. Arthritis Rheum 1991; 34: 325–32
- Ko Y, Mukaida N, Panyutich A, Panyutich A, Voitenok N N, Matsushima K, et al. Establishment of a sensitive enzymelinked inmmunosorbent assay for human interleukin 8. J Immunol Methods 1992; 149: 227–35
- Arnett F C, Edworthy S M, Bloch D A, McShane D J, Fries J F, Cooper N S, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
- Endo H, Akahoshi T, Takagishi K, Kashiwazaki S, Matsushima K. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 1991; 10: 245–52